benzbromarone has been researched along with Diabetes Mellitus in 5 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Considering the increased prevalence of diabetes mellitus (DM) in the gout population, this study evaluated the effects of benzbromarone, a uricosuric agent, on the incidence of DM in the gout population." | 7.88 | Decreased incidence of diabetes in patients with gout using benzbromarone. ( Chang, KT; Chang, YH; Chiu, YW; Hung, CC; Hwang, SJ; Kuo, IC; Lin, HY; Lin, SF; Niu, SW; Ta, A, 2018) |
| " Considering the increased prevalence of diabetes mellitus (DM) in the gout population, this study evaluated the effects of benzbromarone, a uricosuric agent, on the incidence of DM in the gout population." | 3.88 | Decreased incidence of diabetes in patients with gout using benzbromarone. ( Chang, KT; Chang, YH; Chiu, YW; Hung, CC; Hwang, SJ; Kuo, IC; Lin, HY; Lin, SF; Niu, SW; Ta, A, 2018) |
| "Therefore, 35." | 1.51 | Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. ( Fuller, R; Goldenstein-Schainberg, C; Hoff, LS, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoff, LS | 1 |
| Goldenstein-Schainberg, C | 1 |
| Fuller, R | 1 |
| Niu, SW | 1 |
| Chang, KT | 1 |
| Ta, A | 1 |
| Chang, YH | 1 |
| Kuo, IC | 1 |
| Hung, CC | 1 |
| Chiu, YW | 1 |
| Hwang, SJ | 1 |
| Lin, SF | 1 |
| Lin, HY | 1 |
| Day, R | 1 |
| Lee, H | 1 |
| Graham, G | 1 |
| Williams, K | 1 |
| Hiroshige, K | 1 |
| Yuu, K | 1 |
| Takasugi, M | 1 |
| Soejima, M | 1 |
| Kuroiwa, A | 1 |
| Hirai, A | 1 |
| Saito, Y | 1 |
1 review available for benzbromarone and Diabetes Mellitus
| Article | Year |
|---|---|
[Management of hyperuricemia in diabetes].
Topics: Allopurinol; Benzbromarone; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Human | 1997 |
4 other studies available for benzbromarone and Diabetes Mellitus
| Article | Year |
|---|---|
Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
Topics: Adult; Asymptomatic Diseases; Benzbromarone; Brazil; Cross-Sectional Studies; Diabetes Mellitus; Diu | 2019 |
Decreased incidence of diabetes in patients with gout using benzbromarone.
Topics: Adult; Benzbromarone; Comorbidity; Diabetes Mellitus; Disease Progression; Dose-Response Relationshi | 2018 |
Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone).
Topics: Animals; Benzbromarone; Cardiovascular Diseases; Diabetes Mellitus; Female; Gout; Humans; Male; Uric | 2013 |
[A study on uric acid excretion in patients with hypouricemia].
Topics: Acute Kidney Injury; Benzbromarone; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidne | 1993 |